$982,669,952 in Total Settlement Funds Available. See if you qualify!Find Out More

Talis Biomedical Corporation Settlement
(NASDAQ: TLIS)
Settlement

Claim Deadline: March 13, 2025

Settlement Fund: $32,500,000

Settlement Class

All persons or entities that purchased or otherwise acquired common stock issued by Talis pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s February 11, 2021 initial public offering between February 11, 2021 and August 11, 2021, inclusive, and were damaged thereby.

Important Documents

Settlement Status

Preliminarily Approved

Class Period

February 11, 2021 - January 12, 2022

Settlement Hearing Date

March 14, 2025

Opt-Out Deadline

February 21, 2025

Claims Admin

A.B. Data, Ltd.
P.O. Box 173064
Milwaukee, WI 53217
+1 877-331-0411
info@TalisSecuritiesLitigation.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.